Shen Xin, Zhou Nan, Mi Le, Hu Zishuo, Wang Libin, Liu Xueying, Zhang Shengyong
Department of Medicinal Chemistry, School of Pharmacy.
Student Brigade, The Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
Drug Des Devel Ther. 2017 Feb 7;11:313-324. doi: 10.2147/DDDT.S127010. eCollection 2017.
The present study investigated the possible antiobesity and hypoglycemic effects of phloretin (Ph). In an attempt to discover the hypoglycemic effect and potential mechanism of Ph, we used the streptozotocin-induced diabetic rats and (L6) myotubes. Daily oral treatment with Ph for 4 weeks significantly (<0.05) reduced postprandial blood glucose and improved islet injury and lipid metabolism. Glucose consumption and glucose tolerance were improved by Ph via GOD-POD method. Western blot results revealed that the expression of Akt, PI3K, IRS-1, and GLUT4 were upregulated in skeletal muscle of type 2 diabetes (T2D) rats and in L6 myotubes by Ph. The immunofluorescence studies confirmed that Ph improved the translocation of GLUT4 in L6 myotubes. Ph exerted hypoglycemic effects in vivo and in vitro, hence it may play an important role in the management of diabetes.
本研究调查了根皮素(Ph)可能的抗肥胖和降血糖作用。为了发现根皮素的降血糖作用及其潜在机制,我们使用了链脲佐菌素诱导的糖尿病大鼠和(L6)肌管。每天口服根皮素4周可显著(<0.05)降低餐后血糖,并改善胰岛损伤和脂质代谢。通过GOD-POD法,根皮素可改善葡萄糖消耗和葡萄糖耐量。蛋白质免疫印迹结果显示,根皮素可上调2型糖尿病(T2D)大鼠骨骼肌和L6肌管中Akt、PI3K、IRS-1和GLUT4的表达。免疫荧光研究证实,根皮素可改善L6肌管中GLUT4的转位。根皮素在体内和体外均具有降血糖作用,因此它可能在糖尿病管理中发挥重要作用。